Showing results (111-120 of 205) with videos related to
Sort By:
Pageof 21
Prostaglandins & Other Lipid Mediators|July 7, 2019
Relation of oxidized-low-density lipoprotein and high-density lipoprotein subfractions in non-treated patients with coronary artery diseaseXi Zhao, Hui-Wen Zhang, Di Sun, et al.Journal of Geriatric Cardiology : JGC|March 22, 2017
Free triiodothyronine in relation to coronary severity at different ages: Gensini score assessment in 4206 euthyroid patientsBing-Yang Zhou, Yuan-Lin Guo, Na-Qiong Wu, et al.Chinese Medical Journal|March 18, 2006
A randomized comparative study of using enoxaparin instead of unfractionated heparin in the intervention treatment of coronary heart diseaseJi-lin Chen, Jue Chen, Shu-bin Qiao, et al.Biomedical and Environmental Sciences : BES|May 19, 2018
Lipoprotein (a) as a Marker for Predicting the Presence and Severity of Coronary Artery Disease in Untreated Chinese Patients Undergoing Coronary AngiographyDi Sun, Xi Zhao, Sha Li, et al.Metabolism: Clinical and Experimental|December 26, 2021
Lipoprotein (a)-mediated vascular calcification: population-based and in vitro studiesJia Peng, Ming-Ming Liu, Hui-Hui Liu, et al.BMC Endocrine Disorders|October 22, 2020
Association of plasma free fatty acids levels with the presence and severity of coronary and carotid atherosclerotic plaque in patients with type 2 diabetes mellitusMing-Hua Zhang, Ye-Xuan Cao, Li-Guo Wu, et al.Medicine|January 31, 2016
Large HDL Subfraction But Not HDL-C Is Closely Linked With Risk Factors, Coronary Severity and Outcomes in a Cohort of Nontreated Patients With Stable Coronary Artery Disease: A Prospective Observational StudyJian-Jun Li, Yan Zhang, Sha Li, et al.Journal of the American Heart Association|January 10, 2015
Relationship of high-density lipoprotein cholesterol with periprocedural myocardial injury following elective percutaneous coronary intervention in patients with low-density lipoprotein cholesterol below 70 mg/dLXiao-Lin Li, Yuan-Lin Guo, Cheng-Gang Zhu, et al.Medicine|December 31, 2015
Proprotein Convertase Subtilisin/Kexin type 9, C-Reactive Protein, Coronary Severity, and Outcomes in Patients With Stable Coronary Artery Disease: A Prospective Observational Cohort StudyJian-Jun Li, Sha Li, Yan Zhang, et al.Coronary Artery Disease|August 18, 2020
Lipoprotein(a) as a predictor for the presence and severity of premature coronary artery disease: a cross-sectional analysis of 2433 patientsYan-Pu Shi, Ye-Xuan Cao, Jing-Lu Jin, et al.Pageof 21